Clinical Trials Browser

Phase 2 × Interventional × Vascular Endothelial Growth Factor A × Clear all

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

Phase 2 Active not recruiting

Rhabdomyosarcoma

NCT01551745 2021-10-19

Salvage Ovarian FANG™ Vaccine + Bevacizumab

Phase 2 Completed

5 enrolled 9 charts

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01767792 2021-02-12

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

22 enrolled 14 charts

Neurofibromatosis 2

NCT00483834 2019-02-15

A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms